Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 108
Filter
1.
Enferm. foco (Brasília) ; 13: 1-7, dez. 2022. tab
Article in Portuguese | LILACS, BDENF | ID: biblio-1413586

ABSTRACT

Objetivo: Avaliar o perfil e o desfecho clínico de pacientes com sepse e choque séptico em um hospital de trauma de Belo Horizonte. Métodos: Trata-se de estudo transversal, retrospectivo e descritivo dos casos de sepse e choque séptico. Resultados: Constatou-se que 97 (73%) pacientes eram do sexo masculino, com idade entre 19 e 59 anos, 87 (65%) previamente hígidos. Principal motivo de internação foi queda da própria altura com 23 (17%) casos e 37 (28%) diagnósticos de trauma crânio encefálico. Oitenta e seis (65%) pacientes tiveram diagnóstico de sepse e 47 (35%) choque séptico, o principal foco de infecção foi pulmonar 83 (62%). Obtivemos 88 (66%) resultados de hemoculturas negativas e 45 (34%) positivas, 64 (48%) pacientes receberam antibiótico em até 60 minutos após o diagnóstico e o tempo de internação mais prevalente após o evento séptico foi de 7 dias, representado por 31 (46%) pacientes que já estavam internados em uma Unidade de Terapia Intensiva (UTI). Mortalidade de 37 (28%) e 96 (72%) sobreviventes da população estudada. Conclusão: O evento séptico é um problema de saúde pública e tem alta letalidade em pacientes traumatizados. (AU)


Objective: To evaluate the profile and clinical outcome of patients with sepsis and septic shock in a trauma hospital in Belo Horizonte. Methods: This is a cross-sectional, retrospective and descriptive study of cases of sepsis and septic shock. Results: It was found that 97 (73%) patients were male, aged 19 to 59 years, 87 (65%) were previously healthy. Main reason for hospitalization was a fall from one's own height with 23 (17%) cases and 37 (28%) diagnosis of traumatic brain injury. Eighty-six (65%) patients were diagnosed with sepsis and 47 (35%) septic shock, the main focus of infection was pulmonary 83 (62%). We got 88 (66%) negative blood culture results and 45 (34%) positive, 64 (48%) patients received antibiotics within 60 minutes after diagnosis and the most prevalent hospital stay after septic event was 7 days, represented by 31 (46%) patients who were already hospitalized in an Intensive Care Unit (ICU). Mortality of 37 (28%) and 96 (72%) survivors of the population studied. Conclusion: Septic event is a public health problem and has high lethality in traumatized patients. (AU)


Objetivo: Evaluar el perfil y el resultado clínico de los pacientes con sepsis y shock séptico en un hospital de trauma en Belo Horizonte. Métodos: Este es un estudio transversal, retrospectivo y descriptivo de casos de sepsis y shock séptico. Resultados: Se encontró que 97 (73%) pacientes eran hombres, de 19 a 59 años, 87 (65%) antes estaban sanos. La razón principal de la hospitalización fue una caída desde la propia altura con 23 (17%) casos y 37 (28%) diagnóstico de lesión cerebral traumática. Ochenta y seis (65%) pacientes fueron diagnosticados con sepsis y 47 (35%) shock séptico, el foco principal de infección fue pulmonar 83 (62%). Tenemos 88 (66%) resultados negativos del cultivo sanguíneo y 45 (34%) positivo, 64 (48%) los pacientes recibieron antibióticos dentro de los 60 minutos posteriores al diagnóstico y la estancia hospitalaria más frecuente después del evento séptico fue de 7 días, representados por 31 (46%) pacientes que ya estaban hospitalizados en una Unidad de Cuidados Intensivos (UCI). Mortalidad de 37 (28%) y 96 (72%) sobrevivientes de la población estudiada. Conclusión: El evento séptico es un problema de salud pública y tiene alta letalidad en pacientes traumatizados. (AU)


Subject(s)
Humans , Male , Female , Infant , Child, Preschool , Child , Adolescent , Adult , Middle Aged , Aged , Aged, 80 and over , Young Adult , Shock, Septic , Sepsis , Shock, Septic/diagnosis , Shock, Septic/etiology , Shock, Septic/mortality , Epidemiologic Methods , Sepsis/diagnosis , Sepsis/etiology , Sepsis/mortality , Intensive Care Units , Length of Stay/statistics & numerical data
2.
Chinese Journal of Burns ; (6): 335-340, 2022.
Article in Chinese | WPRIM | ID: wpr-936015

ABSTRACT

Objective: To investigate the predictive value of D-dimer for deep venous thrombosis (DVT) of lower extremity in adult burn patients. Methods: A retrospective case series study was conducted. The clinical data of 3 861 adult burn patients who met the inclusion criteria and were admitted to the Department of Burns of Zhengzhou First People's Hospital from January 1, 2015 to December 31, 2019 were collected. The patients were divided into DVT group (n=77) and non-DVT group (n=3 784) according to whether DVT of lower extremity occurred during hospitalization or not. Data of patients in the two groups were collected and compared, including the gender, age, total burn area, D-dimer level, with lower limb burn and inhalation injury or not on admission, with sepsis/septic shock, femoral vein indwelling central venous catheter (CVC), history of surgery, and infusion of concentrated red blood cells or not during hospitalization. Data were statistically analyzed with independent sample t test, Mann-Whitney U test, and chi-square test. The indicators with statistically significant differences between the two groups were analyzed with multivariate logistic regression analysis to screen the independent risk factors for DVT of lower extremity in 3 861 adult burn patients. The receiver operating characteristic (ROC) curve of the independent risk factors predicting DVT of lower extremity in 3 861 adult burn patients were drawn, and the area under the curve (AUC), the optimal threshold value, and the sensitivity and specificity under the optimal threshold value were calculated. The quality of the AUC was compared by Delong test, and the sensitivity and specificity under the optimal threshold value were compared using chi-square test. Results: There were no statistically significant differences in gender, occurrence of sepsis/septic shock or history of surgery during hospitalization between patients in the two groups (P>0.05), while there were statistically significant differences in age, total burn area, D-dimer level, lower limb burn and inhalation injury on admission, and femoral vein indwelling CVC and infusion of concentrated red blood cells during hospitalization between patients in the two groups (t=-8.17, with Z values of -5.04 and -10.83, respectively, χ2 values of 21.83, 5.37, 7.75, and 4.52, respectively, P<0.05 or P<0.01). Multivariate logistic regression analysis showed that age, total burn area, and D-dimer level were the independent risk factors for DVT of lower extremity in 3 861 adult burn patients (with odds ratios of 1.05, 1.02, and 1.14, respectively, 95% confidence intervals of 1.04-1.06, 1.00-1.03, and 1.10-1.20, respectively, P<0.05 or P<0.01). The AUCs of ROC of age, total burn area, and D-dimer level for predicting DVT of lower extremity in 3 861 adult burn patients were 0.74, 0.67, and 0.86, respectively (with 95% confidence intervals of 0.68-0.80, 0.60-0.74, and 0.83-0.89, respectively, P values<0.01), the optimal threshold values were 50.5 years old, 10.5% total body surface area, and 1.845 mg/L, respectively, the sensitivity under the optimal threshold values were 71.4%, 70.1%, and 87.0%, respectively, and the specificity under the optimal threshold values were 66.8%, 67.2%, and 72.9%, respectively. The AUC quality and sensitivity and specificity under the optimal threshold value of D-dimer level were significantly better than those of age (z=3.29, with χ2 values of 284.91 and 34.25, respectively, P<0.01) and total burn area (z=4.98, with χ2 values of 326.79 and 29.88, respectively, P<0.01), while the AUC quality and sensitivity and specificity under the optimal threshold values were similar between age and total burn area (P>0.05). Conclusions: D-dimer level is an independent risk factor for DVT of lower extremity in adult burn patients, its AUC quality and sensitivity and specificity under the optimal threshold value are better than those of age and total burn area, and it has good predictive value for DVT of lower extremity in adult burn patients.


Subject(s)
Adult , Humans , Middle Aged , Burns/complications , Fibrin Fibrinogen Degradation Products/analysis , Lower Extremity/blood supply , Lung Injury/etiology , Prognosis , Retrospective Studies , Shock, Septic/etiology , Venous Thrombosis/etiology
3.
Med. infant ; 27(2): 192-199, Diciembre 2020.
Article in Spanish | BINACIS, UNISALUD, LILACS | ID: biblio-1151212

ABSTRACT

Entre los años 2000 y 2016 en Argentina, se reportaron al Registro Oncopediátrico Hospitalario Argentino (ROHA) 22.450 casos de cáncer en niños menores de 15 años de edad. Las Leucemias constituyen la enfermedad oncológica más frecuente, seguida de los Tumores de Sistema Nervioso Central y los Linfomas. Esta distribución es similar a la descripta en los países desarrollados de Europa y Norteamérica. Su tasa de curación a nivel mundial, llega al 80% debido al uso de quimioterapia intensiva, situación que mejora la supervivencia pero que también aumenta la frecuencia de complicaciones. Estas complicaciones pueden ser debidas tanto al propio cáncer como al tratamiento y en ocasiones ser la primera manifestación de la enfermedad oncológica. Los eventos que amenazan la vida en pacientes inmunocomprometidos son mayores que en la población general, y cuando ocurren tienen una mortalidad elevada. El reconocimiento temprano es clave para el resultado en términos de sobrevida y disminución de la mortalidad. Las acciones deberán centrarse al reconocimiento temprano de eventos críticos en pacientes oncológicos. Los pacientes Hemato-Oncológicos constituyen un gran número de ingresos no planificados a las unidades de cuidados intensivos. Uno de cada 4 pacientes requerirá durante su evolución ingreso a Unidades de Cuidados Intensivos. El propósito de este artículo es describir tres de las urgencias oncológicas que requieren con mayor frecuencia admisión en UCI: la presentación y manejo del shock séptico, Shock Cardiogénico y las complicaciones neurológicas en los pacientes con leucemias agudas (AU)


Between 2000 and 2016, 22,450 cases of cancer in children younger than 15 years of age were reported to the Argentine Hospital Registry of Childhood Cancer (ROHA). Leukemia was the most common cancer reported, followed by central nervous system tumors and lymphoma. This distribution is similar to that described in the developed countries of Europe and North America. The worldwide cure rate is up to 80% due to the use of intensive chemotherapy, which improves survival but also increases the complication rate. These complications may be due both to the cancer itself and to the treatment and are sometimes the first manifestation of the disease. Life-threatening events are more common in immunocompromised patients than in the general population, and when they occur, the mortality rate is high. Early recognition is essential for the outcome in terms of survival and decreased mortality. Interventions should focus on early recognition of critical events in cancer patients. Patients with hematology-oncology diseases account for a large number of unplanned admissions to intensive care units (ICU), while one in four of these patients will require admission to the ICU in the course of their disease. The aim of this study was to describe three oncology emergencies that most frequently require ICU admission: septic shock and its management, cardiogenic shock, and neurological complications in patients with acute leukemia (AU)


Subject(s)
Humans , Infant , Child, Preschool , Child , Adolescent , Shock, Cardiogenic/etiology , Shock, Cardiogenic/therapy , Shock, Septic/etiology , Shock, Septic/therapy , Intensive Care Units, Pediatric , Leukemia, Myeloid, Acute/complications , Central Nervous System Diseases/etiology , Central Nervous System Diseases/therapy , Hematologic Neoplasms/complications , Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications , Survival Rate , Critical Illness/therapy
4.
Article in English | LILACS | ID: biblio-1057206

ABSTRACT

ABSTRACT Objective: To describe a case series of four (4) patients with hemolytic uremic syndrome due to Streptococcus pneumoniae in a level four complexity institution in the city of Bogotá, D.C., Colombia. Cases description: We describe cases of four patients who presented respiratory symptoms and fever. All four patients were in regular conditions on hospital admission, after which they required intensive care and ventilatory support. Upon admission, three cases showed evidence of pleuropulmonary complication. Penicillin-sensitive Streptococcus pneumoniae was isolated in all cases. All patients presented anemia, severe thrombocytopenia, schistocytes on peripheral blood smear, and hyperazotemia. They required blood transfusion and renal replacement therapy during their hospitalization. The patients were diagnosed with hemolytic uremic syndrome due to S. pneumoniae. Three of the four patients had a progressive recovery of the renal function and were discharged after an average of 36 days of hospital stay. The remaining patient had two amputations in the extremities due to thrombotic vascular complications and was discharged after 99 days of hospital stay, requiring hemodialysis every other day. Comments: Hemolytic uremic syndrome due to Streptococcus pneumoniae is a rare but severe complication of invasive pneumococcal disease. Complicated pneumonia is the main condition associated with this entity. It is noteworthy the short period in which these cases were presented, considering the low annual incidence of the disease.


RESUMO Objetivo: Descrever uma série de casos de quatro pacientes com síndrome hemolítico-urêmica por pneumococo em uma instituição de referência em Bogotá, Colômbia. Descrição dos casos: Descrevemos os casos de quatro pacientes que apresentaram sintomas respiratórios e febre. Todos estavam em estado geral regular à admissão hospitalar e necessitaram de cuidados intensivos e suporte ventilatório. Na admissão, em três dos casos foi evidenciada a complicação pleuropulmonar. Isolamento de Streptococcus pneumoniae sensível à penicilina foi realizado em todos os casos. Os quatro pacientes precisaram de transfusão sanguínea e terapia de reposição renal durante a hospitalização. Nos testes laboratoriais, observou-se anemia, trombocitopenia grave, presença de esquizócitos em esfregaço de sangue periférico e hiperazotemia. Com esse quadro, o diagnóstico foi de síndrome hemolítico-urêmica associada à infecção por S. pneumoniae. Houve recuperação progressiva da função renal em três dos quatro pacientes, que tiveram alta após 36 dias de internação hospitalar, em média. Um paciente teve complicações vasculares trombóticas, resultando em duas amputações nas extremidades, e teve alta após 99 dias de internação, com necessidade de hemodiálise em dias alternados. Comentários: A síndrome hemolítico-urêmica por Streptococcus pneumoniae é uma complicação rara, mas grave, da doença invasiva pneumocócica. A pneumonia complicada é a principal condição associada a essa entidade. Destaca-se o curto período em que esses casos foram apresentados, levando em conta a baixa incidência anual de síndrome hemolítico-urêmica.


Subject(s)
Humans , Male , Infant , Child, Preschool , Adolescent , Pneumococcal Infections/complications , Streptococcus pneumoniae/isolation & purification , Hemolytic-Uremic Syndrome/etiology , Hemolytic-Uremic Syndrome/therapy , Pneumococcal Infections/microbiology , Pneumococcal Infections/therapy , Pneumococcal Infections/diagnostic imaging , Pneumonia, Pneumococcal/diagnosis , Shock, Septic/etiology , Thrombosis/surgery , Blood Transfusion/methods , Treatment Outcome , Renal Replacement Therapy/methods , Renal Insufficiency/etiology , Renal Insufficiency/therapy , Hemolytic-Uremic Syndrome/diagnosis , Amputation, Surgical/methods , Length of Stay/statistics & numerical data
5.
Rev. bras. cir. cardiovasc ; 34(5): 615-617, Sept.-Oct. 2019. tab, graf
Article in English | LILACS | ID: biblio-1042032

ABSTRACT

Abstract We report a case of a 59-year-old female patient with vegetative native mitral valve endocarditis caused by Stenotrophomonas maltophilia (SM). She had hemodialysis-dependent chronic renal failure, but no immunosuppressive disease. Echocardiography showed mobile vegetation on her native mitral valve. Right femoral artery embolectomy and mitral valve replacement were performed simultaneously. She awakened from anesthesia, but she passed away due to septic shock complications. To the best of our knowledge, this was the first case in whom native mitral valve endocarditis caused by SM was observed (despite of absence of any immunosuppressive event) and needed to undergo valve replacement.


Subject(s)
Humans , Female , Middle Aged , Gram-Negative Bacterial Infections/surgery , Heart Valve Prosthesis Implantation/methods , Stenotrophomonas maltophilia , Endocarditis, Bacterial/surgery , Heart Valve Diseases/surgery , Mitral Valve/surgery , Shock, Septic/etiology , Gram-Negative Bacterial Infections/complications , Fatal Outcome , Heart Valve Prosthesis Implantation/adverse effects , Endocarditis, Bacterial/complications , Endocarditis, Bacterial/microbiology , Heart Valve Diseases/complications , Heart Valve Diseases/microbiology
6.
J. bras. nefrol ; 41(3): 427-432, July-Sept. 2019. tab
Article in English | LILACS | ID: biblio-1040255

ABSTRACT

Abstract Methotrexate is an effective medication to control several diseases; however, it can be very toxic, being myelosuppression one of its main adverse effects, which increases in severity and frequency in patients with renal failure. We present the case of a 68-year-old man with chronic, end-stage renal disease associated with ANCA vasculitis, under treatment with peritoneal dialysis, who received the medication at a low dose, indicated by disease activity, which presented as a complication with severe pancytopenia with mucositis that improved with support measures and multiple-exchange peritoneal dialysis. We reviewed 20 cases published to date of pancytopenia associated with methotrexate in patients on dialysis and found high morbidity and mortality, which is why its use in this type of patient is not recommended. However, when this complication occurs, a therapeutic option could be the use of multiple-exchange peritoneal dialysis in addition to supportive therapy for drug-related toxicity, although it is recognized that studies are required to show the role of multiple-exchange peritoneal dialysis in the removal of this medication.


Resumo Apesar de sua toxicidade, o metotrexato é um medicamento eficaz no controle de várias doenças. A mielossupressão, um de seus principais efeitos adversos, aumenta em gravidade e frequência nos pacientes com insuficiência renal. Apresentamos o caso de um homem de 68 anos de idade com doença renal terminal relacionada à vasculite associada ao ANCA em diálise peritoneal, que recebeu a medicação em dose baixa em função da atividade da doença e que teve como complicação pancitopenia grave com mucosite, tratada com medidas de suporte e diálise peritoneal com múltiplas trocas. Revisamos 20 casos publicados até o presente momento sobre pancitopenia associada a metotrexato em pacientes em diálise. Foi identificada alta morbidade e mortalidade, razão pela qual seu uso nesse tipo de paciente não é recomendado. No entanto, quando esta complicação ocorre, uma opção terapêutica pode ser o uso de diálise peritoneal com múltiplas trocas, além da terapia de suporte para toxicidade medicamentosa. Maiores estudos são necessários para demonstrar o papel da diálise peritoneal com múltiplas trocas na remoção desse medicamento.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Vasculitis/drug therapy , Methotrexate/adverse effects , Methotrexate/therapeutic use , Peritoneal Dialysis/methods , Folic Acid Antagonists/adverse effects , Folic Acid Antagonists/therapeutic use , Kidney Failure, Chronic/therapy , Pancytopenia/etiology , Pancytopenia/therapy , Shock, Septic/etiology , Shock, Septic/drug therapy , Methotrexate/blood , Treatment Outcome , Mucositis/etiology , Mucositis/drug therapy , Folic Acid Antagonists/blood , Anti-Bacterial Agents/therapeutic use
7.
Rev. bras. ter. intensiva ; 31(3): 368-378, jul.-set. 2019. tab, graf
Article in Portuguese | LILACS | ID: biblio-1042582

ABSTRACT

RESUMO A sepse persiste como importante sobrecarga à saúde pública nos Estados Unidos e em todo o mundo. Com o crescente uso de tecnologias laboratoriais, tem se renovado o interesse na utilização de biomarcadores na sepse, para auxiliar em um processo mais preciso e direcionado para tomadas de decisão. Os peptídeos natriuréticos vem sendo cada vez mais reconhecidos por seu papel que vai além da insuficiência cardíaca. Estes peptídeos estão comumente elevados em pacientes críticos que apresentam condições de disfunção cardiopulmonar e podem ter papel na identificação de pacientes com sepse e choque séptico. São poucos os dados disponíveis em relação ao papel destes biomarcadores no diagnóstico, no controle, nos desfechos e no prognóstico de pacientes sépticos. Esta revisão procura descrever o papel dos peptídeos natriuréticos na ressuscitação volêmica, no diagnóstico de disfunção ventricular, nos desfechos e no prognóstico de pacientes com sepse. Tem sido observado que o peptídeo natriurético tipo B (BNP) e o fragmento N-terminal do peptídeo natriurético tipo B (NT-proBNP) se associam com disfunção ventricular sistólica e diastólica, tanto esquerda quanto direita, em pacientes com cardiomiopatia séptica. O BNP e o NT-proBNP podem predizer a responsividade a volume, e as tendências de medidas seriadas destes peptídeos podem ser importantes na ressuscitação volêmica. A despeito da sugestão de correlação com mortalidade, o papel do BNP nos desfechos de mortalidade e prognóstico, durante a sepse, ainda necessita melhor avaliação.


ABSTRACT Sepsis continues to be a leading public health burden in the United States and worldwide. With the increasing use of advanced laboratory technology, there is a renewed interest in the use of biomarkers in sepsis to aid in more precise and targeted decision-making. Natriuretic peptides have been increasingly recognized to play a role outside of heart failure. They are commonly elevated among critically ill patients in the setting of cardiopulmonary dysfunction and may play a role in identifying patients with sepsis and septic shock. There are limited data on the role of these biomarkers in the diagnosis, management, outcomes and prognosis of septic patients. This review seeks to describe the role of natriuretic peptides in fluid resuscitation, diagnosis of ventricular dysfunction and outcomes and the prognosis of patients with sepsis. B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-proBNP) have been noted to be associated with left ventricular systolic and diastolic and right ventricular dysfunction in patients with septic cardiomyopathy. BNP/NT-proBNP may predict fluid responsiveness, and trends of these peptides may play a role in fluid resuscitation. Despite suggestions of a correlation with mortality, the role of BNP in mortality outcomes and prognosis during sepsis needs further evaluation.


Subject(s)
Humans , Peptide Fragments/physiology , Sepsis/complications , Sepsis/etiology , Sepsis/mortality , Sepsis/therapy , Natriuretic Peptide, Brain/physiology , Prognosis , Shock, Septic/complications , Shock, Septic/etiology , Shock, Septic/mortality , Shock, Septic/therapy , Treatment Outcome , Ventricular Dysfunction, Left/etiology , Fluid Therapy
8.
Rev. bras. queimaduras ; 18(1): 59-61, jan.-abr. 2019.
Article in Portuguese | LILACS | ID: biblio-1100109

ABSTRACT

Cerca de 6% das crianças com queimadura necessitam de internação hospitalar e a mortalidade por queimadura é superior nas crianças mais novas comparativamente às mais velhas. A síndrome do Choque Tóxico (SCT) é uma afecção rara e potencialmente fatal se não diagnosticada e tratada rapidamente. O caso a seguir mostra uma criança de 3 anos vítima de queimaduras de segundo e terceiro graus que evoluiu com SCT, além de uma breve discussão sobre os principais pontos-chave do diagnóstico e tratamento.


About 6% of children with burns require hospitalization and mortality from burns is higher in younger children compared to older ones. Toxic Shock syndrome (TSS) is a rare and potentially fatal condition if not diagnosed and treated quickly. The following case shows a three-year-old child suffering from second and third degree burns who evolved with TSS, as well as a brief discussion of the main key points of diagnosis and treatment.


Alrededor del 6% de los niños con quemaduras requieren hospitalización y la mortalidad por quemaduras es mayor en los niños más pequeños en comparación con los mayores. El síndrome de Shock Tóxico (SST) es una condición rara y potencialmente mortal si no se diagnostica y trata rápidamente. El siguiente caso muestra a un niño de 3 años víctima de quemaduras de segundo y tercer grado que evolucionó con SST, así como una breve discusión sobre los principales puntos clave del diagnóstico y el tratamiento.


Subject(s)
Humans , Child, Preschool , Shock, Septic/etiology , Burns/complications , Child Care/methods , Burn Units , Intensive Care Units
9.
Rev. Soc. Bras. Clín. Méd ; 16(4): 208-211, out.-dez. 2018. tab.
Article in Portuguese | LILACS | ID: biblio-1025794

ABSTRACT

OBJETIVO: Avaliar a frequência de sepse em gestantes e puérperas atendidas em um hospital, identificar os principais focos originários de sepse na gestação e puerpério, e verificar os principais agentes etiológicos envolvidos em sua etiopatogenia. MÉTODOS: Estudo do tipo transversal descritivo realizado no Hospital do Trabalhador, em Curitiba (PR), de agosto de 2014 a agosto de 2016. Revisão e análise de 71 prontuários de pacientes diagnosticadas com sepse, sepse grave ou choque séptico. Os aspectos estudados foram idades gestacional, agente etiológico, foco infeccioso, principal trimestre gestacional acometido e prevalência de cada tipo de sepse. RESULTADOS: A frequência de sepse durante a gestação e o puerpério no período estudado foi de nove casos para cada mil gestantes. A ocorrência de sepse foi relacionada principalmente ao segundo semestre gestacional (39,4%). Os casos de sepse somaram 73,2% do total, enquanto os demais evoluíram com quadros de sepse grave e choque séptico . Escherichia coli representou 33,8%, sendo o urinário o foco infeccioso mais prevalente (70,4%). Ceftriaxona foi o antibiótico mais utilizado, tanto isoladamente quanto em associação (84,4%). Entre os desfechos para o feto, 85,9% não tiveram complicações. CONCLUSÕES: Os novos conceitos de sepse publicados pela Society of Critical Care Medicine (SCCM) e pela European Society of Critical Care Medicine (ESICM) contrariam os interesses dos países conhecidos como de baixos e médios recursos. Foi encontrado aumento da incidência de sepse gestacional, ocorrendo prevalência do foco urinário; consequentemente, o agente principal foi E. coli. Ademais, ocorreram importantes consequências perinatais como mortalidade e prematuridade. (AU)


OBJECTIVE: To evaluate the frequency of sepsis in pregnant and puerperal patients attended in a hospital, and to identify the main focus of sepsis during gestation and puerperium, and check the main etiological agents involved in its pathogenesis. METHODS: This is a cross-sectional and descriptive study carried out at Hospital do Trabalhador (city of Curitiba, state of Paraná), from August 2014 to August 2016. It is a review and analysis of the charts of 71 patient diagnosed with sepsis, severe sepsis, or septic shock. Aspects studied: gestational age, etiologic agent, infectious focus, main affected gestational trimester, and prevalence of each type of sepsis. RESULTS: The frequency of sepsis during pregnancy and puerperium was 9 cases for 1000 pregnant women. The occurrence of sepsis was mainly related to the second gestational semester (39.4%). Severe sepsis and septic shock comprised 73.2% of the cases. Escherichia coli accounted for 33.8%, and the most prevalent infectious focus was urinary (70.4%). Ceftriaxone was the most commonly used antibiotic, both alone and in combination (84.4%). Among the outcomes for the fetus, 85.9% had no complications. CONCLUSIONS: The new concepts of sepsis, published by the Society of Critical Care Medicine (SCCM), and by the European Society of Critical Care Medicine (ESICM) contradict the interests of the countries with low and medium resources. An increase in the incidence of gestational sepsis occurred, with a prevalence of urinary focus; consequently the main agent was Escherichia coli. In addition, there were important perinatal consequences such as mortality and prematurity. (AU)


Subject(s)
Humans , Female , Pregnancy , Pregnancy Complications, Infectious/epidemiology , Puerperal Infection/epidemiology , Pregnancy Complications, Infectious/etiology , Pregnancy Complications, Infectious/drug therapy , Puerperal Infection/etiology , Puerperal Infection/drug therapy , Shock, Septic/etiology , Shock, Septic/epidemiology , Urinary Tract Infections/complications , Urinary Tract Infections/drug therapy , Ceftriaxone/therapeutic use , Infant, Premature , Maternal Mortality , Medical Records/statistics & numerical data , Cross-Sectional Studies , Gestational Age , Fetal Mortality , Escherichia coli Infections/complications , Escherichia coli Infections/drug therapy , Anti-Bacterial Agents/therapeutic use
10.
Rev. gastroenterol. Perú ; 38(3): 301-309, jul.-set. 2018. tab
Article in Spanish | LILACS | ID: biblio-1014100

ABSTRACT

Vibrio cholerae serogrupo NO-O1/NO-O139 (VCNO) es causa infrecuente de gastroenteritis. Sin embargo, se le asocia a infección extra-intestinal severa en huéspedes inmunocomprometidos, y entre ellas, la bacteremia en pacientes con cirrosis hepática es digna de mención. A continuación, presentamos el caso de una mujer de 58 años, con el diagnóstico de cirrosis hepática de fondo, que desarrolló progresivamente choque séptico, disfunción orgánica múltiple y desenlace fatal al cuarto día de su admisión. Los resultados obtenidos post mortem, de los hemocultivos previamente tomados, aislaron bacilos gram negativos compatibles con Vibrio cholerae. Posteriormente, se identificó el serogrupo NO-O1/NO-O139, a través de aglutinación en placa y PCR negativo para el gen ctxA. El antibiograma mostró susceptibilidad conservada a ampicilina, cloranfenicol, tetraciclina y ciprofloxacino, con resistencia al trimetoprim-sulfametoxazol. El presente caso, descrito en el Hospital Nacional Dos de Mayo, es hasta la fecha, el primer reporte de bacteremia VCNO en el Perú.


Non-O1, non-O139 Vibrio cholerae (NOVC) strains are an uncommon cause of gastroenteritis. However, they have been recently associated with severe extraintestinal infections in immunocompromised hosts. Among them, bacteremia in cirrhotic patients is noteworthy. We present the case of a 58-year-old woman with cirrhosis that developed septic shock, multiple organ failure and died four days after admission. Blood cultures yielded Gram-negative rods identified as Vibrio cholerae. Further serogrouping by slide agglutination and a negative PCR for ctxA gen confirmed the strain to be NOVC. Antimicrobial susceptibility testing showed sensitivity to ampicillin, chloramphenicol, tetracycline and ciprofloxacin; and resistance to trimethoprim-sulfamethoxazole. To the best of our knowledge, this is first report in Peru, described in the Hospital Nacional Dos de Mayo, of NOVC bacteremia.


Subject(s)
Female , Humans , Middle Aged , Cholera/microbiology , Bacteremia/microbiology , Vibrio cholerae O139/isolation & purification , Vibrio cholerae non-O1/isolation & purification , Liver Cirrhosis/complications , Peru/epidemiology , Shock, Septic/etiology , Serotyping , Peptic Ulcer Hemorrhage/complications , Cholera/complications , Cholera/epidemiology , Bacteremia/epidemiology , Fatal Outcome , Drug Resistance, Multiple, Bacterial , Disease Susceptibility , Multiple Organ Failure/etiology
11.
Medicentro (Villa Clara) ; 21(3): 268-272, jul.-set. 2017.
Article in Spanish | LILACS | ID: biblio-894391

ABSTRACT

La hemorragia pulmonar y el síndrome de dificultad respiratoria aguda son complicaciones infrecuentes de la fiebre tifoidea, y la endotoxemia producto de la sepsis es un factor causal común. Se describe a un paciente de sexo masculino, indio, joven, inmunocompetente, con hemorragia pulmonar, síndrome de dificultad respiratoria aguda y choque séptico en el curso de la fiebre tifoidea, con hemocultivos negativos y cepa de Salmonella typhi, aislada en coprocultivo, resistente a la ciprofloxacina. El paciente tuvo una respuesta satisfactoria al tratamiento convencional para el daño pulmonar con ventilación mecánica, el antibiótico por sensibilidad del antibiograma y la administración de hemoderivados.


Subject(s)
Respiratory Distress Syndrome/etiology , Shock, Septic/etiology , Typhoid Fever/complications
13.
Rev. chil. pediatr ; 87(2): 143-147, abr. 2016. ilus
Article in Spanish | LILACS | ID: lil-783497

ABSTRACT

Introducción A partir de julio de 2015, en el estado de Yucatán, México, se presentó un brote de chikungunya. Objetivo Analizar el curso clínico de un caso de chikungunya de trasmisión vectorial y proporcionar evidencia práctica que sirva para orientar impresiones diagnósticas y pronósticas futuras en áreas endémicas y períodos de brote. Reporte de caso Lactante de un mes de edad, sin antecedentes de importancia, quien presentó cuadro febril acompañado de eritema maculopapular, inicialmente tratado con antiinflamatorios no esteroideos. Evolucionó con hipoactividad, trombocitopenia severa y neutropenia sin linfopenia, dificultad respiratoria, disfunción hepática, convulsiones y posteriormente shock séptico con desenlace fatal. La IgM para chikungunya fue positiva en la paciente, mientras que en su madre fue negativa. En el hemocultivo creció Pseudomonas aeruginosa, por posible contaminación, sin descartarse una sepsis de origen mixto. Conclusiones Chikungunya es una enfermedad cuyas manifestaciones en los neonatos y lactantes pueden ser graves e incluso fatales. Es importante sospecharla en este grupo etario debido al riesgo de contacto vectorial, en presencia de fiebre sin foco aparente y manifestaciones cutáneas maculares o maculopapulares. Los antipiréticos se deben emplear con precaución, considerando la posibilidad de agravar el cuadro clínico subyacente, con potencial daño hepático y hematológico.


Introduction A chikungunya outbreak took place in the State of Yucatan starting in the second half of 2015 Objective To analyse the clinical course of a case of chikungunya in a previously healthy infant, providing practical evidence to guide future diagnoses and treatment during outbreak seasons in endemic areas Case report Clinical manifestation started with a sudden onset of fever and a diffuse macular-papillary erythema, originally treated in the community with non-steroidal anti-inflammatory drugs. Two days later, the fever relapsed with hypoactivity, severe thrombocytopenia and neutropenia (without lymphopenia), respiratory distress, liver dysfunction, sepsis, followed by septic shock with a fatal outcome. IgM test was positive to chikungunya, while her mother tested negative. Pseudomonas aeruginosa was isolated from the blood culture possible due to contamination, without ruling out the possibility of a mixed origin sepsis. Conclusions Chikungunya is a disease in which the manifestations in neonates and young infants can be severe, and even fatal. It is important to suspect it in this age group at risk of vector contact, in the presence of fever without apparent source of infection and cutaneous manifestations. It is important to use the antipyretics cautiously, considering the possibility of aggravating the underlying infection, and the potential hepatic and haematological damage.


Subject(s)
Humans , Female , Infant , Shock, Septic/etiology , Fever/etiology , Chikungunya Fever/complications , Shock, Septic/virology , Disease Outbreaks , Fatal Outcome , Fever/virology , Chikungunya Fever/diagnosis , Chikungunya Fever/physiopathology , Mexico
14.
Int. braz. j. urol ; 42(2): 270-276, Mar.-Apr. 2016. tab, graf
Article in English | LILACS | ID: lil-782867

ABSTRACT

ABSTRACT Introduction: To investigate the role of initial procalcitonin (PCT) level as an early predictor of septic shock for the patient with sepsis induced by acute pyelonephritis (APN) secondary to ureteral calculi. Materials and Methods: The data from 49 consecutive patients who met criteria of sepsis due to APN following ureteral stone were collected and divided into two groups: with (n=15) or without (n=34) septic shock. The clinical variables including PCT level for this outcome were retrospectively compared by univariate analysis, followed by multivariable logistic regression model. Results: All subjects had hydronephrosis, and were hospitalized with the mean of 11.8 days (3–42 days). The mean size of the ureteral stones was 7.5mm (3–30mm), and 57% were located in upper ureter. At univariate analysis, patients with septic shock were significantly older, a higher proportion had hypertension, lower platelet count and serum albumin level, higher CRP and PCT level, and higher positive blood culture rate. Multivariate models indicated that lower platelet count and higher PCT level are independent risk factors (p=0.043 and 0.046, respectively). In ROC curve, the AUC was significantly wider in PCT (0.929), compared with the platelet count (0.822, p=0.004). At the cut-off of 0.52ng/mL, the sensitivity and specificity were 86.7% and 85.3%. Conclusion: Our study demonstrated elevated initial PCT levels as an early independent predictor to progress into septic shock in patients with sepsis associated with ureteral calculi.


Subject(s)
Humans , Male , Female , Adult , Aged , Aged, 80 and over , Young Adult , Pyelonephritis/blood , Shock, Septic/blood , Calcitonin/blood , Ureteral Calculi/blood , Platelet Count , Pyelonephritis/etiology , Reference Values , Shock, Septic/etiology , C-Reactive Protein/analysis , Serum Albumin/analysis , Biomarkers/blood , Ureteral Calculi/complications , Acute Disease , Predictive Value of Tests , Reproducibility of Results , Retrospective Studies , Risk Factors , ROC Curve , Analysis of Variance , Statistics, Nonparametric , Disease Progression , Emergency Service, Hospital , Middle Aged
15.
Rev. chil. cir ; 67(1): 79-87, feb. 2015. tab
Article in Spanish | LILACS | ID: lil-734744

ABSTRACT

Severe sepsis is a common condition, increasing in incidence and mortality. Despite it has always been part of the surgeon's clinical practice, severe sepsis of surgical origin remains difficult to manage. Decisions about initial resuscitation, timing of source control, surgical technique and antimicrobial therapy are challenging. The goal of this review is to ensure surgeons and other health professionals are aware of diagnostic and treatment choices actually recommended in order to reduce the high mortality of surgical severe sepsis.


La sepsis severa es una condición clínica frecuente, cuya incidencia y mortalidad van en aumento. Aunque siempre ha sido parte de la práctica clínica del cirujano, la sepsis severa de causa quirúrgica sigue siendo un cuadro clínico difícil de manejar. Las decisiones sobre reanimación del paciente, momento de la cirugía, técnica quirúrgica a utilizar y uso de antibióticos son un desafío. El objetivo de esta revisión es que el cirujano y el equipo médico conozcan las alternativas diagnósticas y terapéuticas actualmente recomendadas para reducir la alta mortalidad de la sepsis severa de causa quirúrgica.


Subject(s)
Humans , Surgical Procedures, Operative/adverse effects , Sepsis/diagnosis , Sepsis/etiology , Sepsis/therapy , Anti-Bacterial Agents/administration & dosage , Shock, Septic/diagnosis , Shock, Septic/etiology , Early Diagnosis , Systemic Inflammatory Response Syndrome/diagnosis , Systemic Inflammatory Response Syndrome/etiology
17.
Biomédica (Bogotá) ; 34(supl.1): 58-66, abr. 2014. graf, tab
Article in Spanish | LILACS | ID: lil-712422

ABSTRACT

Introducción. La bacteriemia es una de las infecciones hospitalarias de mayor mortalidad, especialmente en las unidades de cuidados intensivos, donde es más frecuente. Pseudomonas aeruginosa es uno de los causantes de bacteriemia más agresivos. Objetivo. Evaluar la asociación entre el tratamiento antibiótico inicial y la mortalidad hospitalaria en estos pacientes. Materiales y métodos. Se trata de un estudio de cohorte retrospectivo multicéntrico realizado entre 2005 y 2008. Se consideró tratamiento adecuado aquel iniciado en las primeras 48 horas del diagnóstico que incluyera, al menos, una dosis de antibiótico intravenoso al que P. aeruginosa fuera sensible y hubiera sido suministrado en la dosis y frecuencia recomendadas. El desenlace principal fue la mortalidad hospitalaria en un lapso de 30 días. Se hizo pareo según grado de exposición usando índices de propensión y, posteriormente, análisis paramétrico de supervivencia. Resultados. Se incluyeron 164 pacientes. La mediana de edad y la clasificación del APACHE II ( Acute Physiology and Chronic Health Evaluation II ) fue de 56 y 13, respectivamente. Se identificó la fuente de la bacteriemia en 68,3 % de los casos, y la más frecuente fue el tracto respiratorio; 44 % de los pacientes recibió tratamiento inadecuado, y la resistencia bacteriana fue la principal variable asociada. La proporción de incidencia de sepsis grave, choque séptico, falla orgánica múltiple y muerte en el lapso de 30 días fue de 67,7, 50, 41,5 y 43,9 %, respectivamente. El tratamiento adecuado se asoció a una prolongación del tiempo hasta el evento (razón de tiempo ajustada, 2,95, IC 95%, 1,63 a 5,33). Conclusión. El tratamiento antibiótico inicial adecuado es un factor protector contra la mortalidad hospitalaria en pacientes con bacteriemia por P. aeruginosa .


Introduction: Among hospital-acquired infections, bacteremia is one of the leading causes of mortality worldwide, especially among intensive care unit patients, where it is more frequent. Pseudomonas aeruginosa is one of the most aggressive agents causing bacteremia. Objective: To evaluate the association between initial antimicrobial therapy and hospital mortality in these patients. Materials and methods: A multicenter and retrospective cohort study was conducted between 2005 and 2008. Antimicrobial therapy was considered adequate if it included at least one intravenous antibiotic to which the P. aeruginosa isolate was susceptible in vitro, was administered at the recommended dose and frequency for bacteremia, and initiated within the first 48 hours from diagnosis. The main outcome was 30-day hospital mortality. Patients were paired according to exposure level using propensity score matching, and then a parametric survival model was fitted. Results: One hundred and sixty four patients were included. Median age and the APACHE II score were 56 and 13, respectively. The source of bacteremia was identified in 68.3 % of cases, the respiratory tract being the most frequent. Forty-four percent of patients received inadequate therapy, with bacterial resistance as the main associated variable. The incidence of severe sepsis, septic shock, multiple organ failure and death within the first 30 days was 67.7, 50, 41.5 and 43.9%, respectively. Adequate therapy was associated with a longer time to the event (adjusted time ratio, 2.95, 95% CI, 1.63 to 5.33). Conclusion: Adequate initial antimicrobial therapy is a protective factor against hospital mortality in patients with P. aeruginosa bacteremia.


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Critical Illness/mortality , Drug Resistance, Multiple, Bacterial , Pseudomonas Infections/drug therapy , APACHE , Anti-Bacterial Agents/administration & dosage , Bacteremia/mortality , Colombia/epidemiology , Follow-Up Studies , Hospital Mortality , Hospitals, Urban/statistics & numerical data , Intensive Care Units/statistics & numerical data , Multiple Organ Failure/etiology , Multiple Organ Failure/mortality , Pseudomonas Infections/mortality , Retrospective Studies , Shock, Septic/etiology , Shock, Septic/mortality , Treatment Failure , Tertiary Care Centers/statistics & numerical data
18.
Rev. bras. ter. intensiva ; 25(1): 6-11, jan.-mar. 2013. graf, tab
Article in Portuguese | LILACS | ID: lil-673360

ABSTRACT

OBJETIVO: Avaliar os níveis séricos de proteína C-reativa em pacientes com sepse pulmonar e abdominal nos primeiros 5 dias de progressão da sepse. MÉTODOS: Estudo de coorte retrospectivo em hospital universitário. Foram selecionados 345 pacientes admitidos em unidade de terapia intensiva e diagnosticados com sepse de origem pulmonar ou abdominal. A dosagem sérica de proteína C-reativa foi realizada por imunoensaio turbidimétrico. Para análises da proteína C-reativa, o dia 1 foi definido como o do diagnóstico clínico da sepse. RESULTADOS: Foram avaliados 34 pacientes com sepse (9,8%), 114 com sepse grave (33,0%) e 197 com choque séptico (57,2%). A idade dos pacientes foram 56,4±19,8 anos. Concentrações séricas de proteína C-reativa foram mais elevadas no dia do diagnóstico de sepse no grupo com infecção de origem abdominal em comparação ao grupo com sepse pulmonar (17,8±10,1 mg/dL versus 14,9±11,1 mg/dL; p=0,025) e mantiveram-se significativamente mais elevadas nos primeiros 5 dias de evolução da sepse. CONCLUSÃO: As concentrações séricas de proteína C-reativa foram significativamente mais elevadas nos pacientes com sepse de origem abdominal do que em pacientes com sepse de origem pulmonar nos 5 primeiros dias de evolução da sepse.


OBJECTIVES: To evaluate the C-reactive protein serum levels in patients with pulmonary and abdominal sepsis during the first five days of sepsis progression. METHODS: The present investigation was a retrospective cohort study conducted at the university hospital with 345 patients who were admitted to the intensive care unit and diagnosed with sepsis of pulmonary or abdominal origin. Serum C-reactive protein concentrations were measured by the turbidimetric immunoassay. For analysis of C-reactive protein, day 1 was defined as the day on which the patient was clinically diagnosed with sepsis. RESULTS: Thirty-four patients with sepsis (9.8%), 114 patients with severe sepsis (33.0%), and 197 patients with septic shock (57.2%) were evaluated. The age of the patients was 56.4±19.8 years. The serum C-reactive protein concentrations were higher on the day of sepsis diagnosis in the group with abdominal infection compared with the group with pulmonary sepsis (17.8±10.1 mg/dL versus 14.9±11.1 mg/dL, p=0.025) and remained significantly higher during the first five days of sepsis progression. CONCLUSION: The serum C-reactive protein concentrations were significantly higher in the patients with abdominal sepsis compared with the patients with pulmonary sepsis during the first five days of sepsis progression.


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , C-Reactive Protein/analysis , Intensive Care Units , Sepsis/blood , Shock, Septic/blood , Abdomen , Cohort Studies , Disease Progression , Hospitals, University , Lung Diseases/complications , Nephelometry and Turbidimetry , Retrospective Studies , Sepsis/etiology , Shock, Septic/etiology
19.
West Indian med. j ; 62(3): 224-229, Mar. 2013. ilus, tab
Article in English | LILACS | ID: biblio-1045630

ABSTRACT

OBJECTIVE: To describe the incidence, treatment and outcomes of patients with severe sepsis and septic shock in a setting where early goal directed therapy (EGDT) is not routinely performed. METHOD: An observational study of all adult patients admitted from the emergency department (ED) of the University Hospital of the West Indies (UHWI) with a diagnosis of severe sepsis and septic shock from July 5, 2007 to September 1, 2008 was conducted. Baseline parameters, treatment patterns and inhospital outcomes were evaluated. RESULTS: A total of 58 011 patients were seen and 762 (1.3%) had sepsis, 117 (15.4%) of whom were classified as severe sepsis or septic shock. Mean (SD) age was 59.2 (23.3) years and 49% were female. Medical history included hypertension (29%), diabetes mellitus (26%), stroke (8%), heart failure (6%) and HIV (6%). The most common sources of sepsis were pneumonia (67%) and urinary tract infection (46%). Median, interquartile range (IQR) time from triage to antibiotic administration was 126 (88, 220) minutes and antibiotics were given to 65.7% within three hours. Overall, organisms were sensitive to empirical antibiotics in 69%. Median (IQR) lactate was 5.3 (4.5, 7.5) mmol/L. Most patients (95%) were admitted to the ward; 1% went to the intensive care unit (ICU) and 2% died in the ED. Mean (SD) length of hospital stay was 9.5 (10.3) days. Inhospital mortality was 25% and survival correlated inversely with age (r pb = 0.25; p = 0.006). CONCLUSION: Despite a lack of EGDT, sepsis treatment patterns were consistent with "bestpractice" and mortality was lower than international comparators.


OBJETIVO: Describir la incidencia, el tratamiento y los resultados para pacientes con sepsis severa y shock séptico en un entorno donde la terapia dirigida por metas tempranas (TDMT) no se realiza de modo rutinario. MÉTODO: Se realizó un estudio observacional de todos los pacientes adultos con diagnóstico de sepsis severa y shock séptico, ingresados en la Sala de Emergencias del Hospital Universitario de West Indies (HUWI) desde el 5 de julio de 2007 al 1ero. de septiembre de 2008. Se evaluaron los parámetros iniciales de referencia, los patrones de tratamiento, y la evolución intrahospitalaria. RESULTADOS: Un total de 58 011 pacientes fueron vistos, 762 (1.3%) de ellos con sepsis. De estos casos con sepsis, 117 (15.4%) fueron clasificados como sepsis severa o shock séptico. La edad media (SD) fue 59.2 (23.3) años y 49% eran mujeres. Historia clínica incluía hipertensión (29%), diabetes (26%), accidente cerebrovascular (8%), insuficiencia cardíaca (6%) y VIH (6%). Las fuentes más comunes de la sepsis fueron neumonía (67%) e infección del tracto urinario (46%). La mediana del tiempo (IQR) transcurrido desde la selección (triaje) hasta la administración de antibióticos fue 126 (88, 220) minutos, y los antibióticos fueron entregados al 65.7% dentro de las tres horas. En general, los organismos fueron sensibles a los antibióticos empíricos en 69%. La mediana del lactato (IQR) fue 5.3 (4.5, 7.5) mmol/L. La mayoría de los pacientes (95%) fueron ingresados a la sala; 1% se destinó a la unidad de cuidados intensivos (UCI), y el 2% murió en la Sala de Emergencias. El promedio (SD) de la estancia hospitalaria fue de 9.5 (10.3) días. La mortalidad intrahospitalaria fue de 25%, y la supervivencia se halló en correlación inversa con la edad (rpb = .25; p = 0.006). CONCLUSIÓN: A pesar de la falta de TDMT, los patrones del tratamiento de sepsis fueron consistentes con las "mejores prácticas", y la mortalidad fue menor comparada con los datos de comparación a nivel internacional.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Sepsis/drug therapy , Anti-Bacterial Agents/therapeutic use , Pneumonia/complications , Shock, Septic/etiology , Shock, Septic/drug therapy , Shock, Septic/epidemiology , Urinary Tract Infections/complications , Severity of Illness Index , Comorbidity , Prospective Studies , Cohort Studies , Hospital Mortality , Sepsis/etiology , Sepsis/epidemiology , Diabetes Mellitus/epidemiology , Emergency Service, Hospital , Time-to-Treatment/statistics & numerical data , Hypertension/epidemiology , Jamaica/epidemiology , Length of Stay/statistics & numerical data
20.
Annals of Laboratory Medicine ; : 283-287, 2013.
Article in English | WPRIM | ID: wpr-105284

ABSTRACT

Sphingobacterium spiritivorum has been rarely isolated from clinical specimens of immunocompromised patients, and there have been no case reports of S. spiritivorum infection in Korea to our knowledge. We report a case of S. spiritivorum bacteremia in a 68-yr-old woman, who was diagnosed with acute myeloid leukemia and subsequently received chemotherapy. One day after chemotherapy ended, her body temperature increased to 38.3degrees C. A gram-negative bacillus was isolated in aerobic blood cultures and identified as S. spiritivorum by an automated biochemical system. A 16S rRNA sequencing analysis confirmed that the isolate was S. spiritivorum. The patient received antibiotic therapy for 11 days but died of septic shock. This is the first reported case of human S. spiritivorum infection in Korea. Although human infection is rare, S. spiritivorum can be a fatal opportunistic pathogen in immunocompromised patients.


Subject(s)
Aged , Female , Humans , Anti-Bacterial Agents/therapeutic use , Bacteremia/complications , Bone Marrow Cells/pathology , Fatal Outcome , Immunocompromised Host , Leukemia, Myeloid, Acute/complications , Phylogeny , RNA, Ribosomal, 16S/genetics , Sequence Analysis, DNA , Shock, Septic/etiology , Sphingobacterium/classification
SELECTION OF CITATIONS
SEARCH DETAIL